Health

Short Sleep Duration Linked to Multimorbidity

A prospective UK cohort study suggested that short sleep duration was associated with the onset of chronic disease and multimorbidity. The study included 7,864 (32.5% women) participants free of multimorbidity. Self-reported sleep duration was measured 6 times between 1985 and 2016. Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases and followed up to 2019. There were 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours at age 50. Compared to 7-hour sleep, sleep duration ≤5 hours at age 50, 60 and 70 were all associated with higher multimorbidity risk (hazard ratio: 1.30, 1.32, and 1.40, respectively). Due to the small number of cases in the sleep duration ≥9 hours category, not allowing conclusions to be drawn for this category. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20) and, among those who developed a first disease, with subsequent multimorbidity (1.21). However, no association was found between sleep duration and mortality among those with existing chronic diseases. The findings are in line with previous studies and support the role of short sleep duration in chronic diseases. Source: https://journals.plos.org/

hyangiu

Recent Posts

Mindfulness-Based Stress Reduction on Par with Escitalopram for Anxiety Disorders

Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…

3 days ago

Key Messages of 2024 ESC Guidelines for High BP

The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…

1 month ago

CRP, LDL Cholesterol, and Lipoprotein(a) Levels Predictive of CVD

A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…

1 month ago

No Benefit to Stop Beta-Blockers After MI

A French multicenter, open label, randomized, noninferiority trial suggested that interruption of long-term beta-blocker treatment…

2 months ago

Plant vs Animal Fat on Mortality

A US prospective cohort study demonstrated that replacement of animal fat with an equivalent amount…

2 months ago

UK T2D Remission Program Findings

An ongoing UK national prospective program shows remission of type 2 diabetes (T2D) outside of…

2 months ago

This website uses cookies.